November 4, 2009

Xiaolong Jiang, Zhang-jin Zhang, Steven Zhang, Eleanore H Gamble, Min Jia, Robert J Ursano, and He Li

5-HT_2A receptor antagonism by MDL 11,939 during inescapable stress prevents subsequent exaggeration of acoustic startle response and reduced body weight in rats
J Psychopharmacol first published on November 4, 2009 as doi:10.1177/0269881109106911
[Abstract] [OnlineFirst PDF]  

October 20, 2009

Helen Tibboel, Jan De Houwer, and Matt Field

Reduced attentional blink for alcohol-related stimuli in heavy social drinkers
J Psychopharmacol first published on October 20, 2009 as doi:10.1177/0269881109106977
[Abstract] [OnlineFirst PDF]  

October 14, 2009

Andrea Cipriani, Jennifer Rendell, and John R Geddes

Olanzapine in the long-term treatment of bipolar disorder: A systematic review and meta-analysis
J Psychopharmacol first published on October 14, 2009 as doi:10.1177/0269881109106900
[Abstract] [OnlineFirst PDF]  

October 13, 2009

Jean-Michel Le Melledo, Jorge Perez-Parada, Jarret Morrow, Francois Bellavance, Nathalie Lara, Farideh Jahandar, Robert Granger, Glendon Tait, and Karen McManus

Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106922
[Abstract] [OnlineFirst PDF]  

María S García-Gutiérrez and Jorge Manzanares

The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106910
[Abstract] [OnlineFirst PDF]  

Ulrich Hegerl and R Mergl

The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106930
[Abstract] [OnlineFirst PDF]  

Berthold Langguth, Michael Landgrebe, Markus Wittmann, Tobias Kleinjung, and Göran Hajak

Persistent tinnitus induced by tricyclic antidepressants
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106929
[OnlineFirst PDF]  

Christopher Gonano, Daniela Latzke, Manuel Sabeti-Aschraf, Stephan C Kettner, Astrid Chiari, and Burkhard Gustorff

The anxiolytic effect of pregabalin in outpatients undergoing minor orthopaedic surgery
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106928
[Abstract] [OnlineFirst PDF]  

Janice Bartholomew, Steve Holroyd, and Thomas M Heffernan

Does cannabis use affect prospective memory in young adults?
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106909
[Abstract] [OnlineFirst PDF]  

Kristina Annerbrink, Marie Olsson, Jan Hedner, and Elias Eriksson

Acute and chronic treatment with serotonin reuptake inhibitors exert opposite effects on respiration in rats: possible implications for panic disorder
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106908
[Abstract] [OnlineFirst PDF]  

Parisa Hasanein

Two histamine H₂ receptor antagonists, zolantidine and cimetidine, modulate nociception in cholestatic rats
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106912
[Abstract] [OnlineFirst PDF]  

Stefano Pallanti, Silvia Bernardi, Andrea Allen, and Eric Hollander

Serotonin function in pathological gambling: blunted growth hormone response to Sumatriptan
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106907
[Abstract] [OnlineFirst PDF]  

Wakako Umene-Nakano, Reiji Yoshimura, Nobuhisa Ueda, Akihito Suzuki, Atsuko Ikenouchi-Sugita, Hikaru Hori, Koichi Otani, and Jun Nakamura

Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106899
[Abstract] [OnlineFirst PDF]  

Natasa Hlavacova, Jan Bakos, and Daniela Jezova

Eplerenone, a selective mineralocorticoid receptor blocker, exerts anxiolytic effects accompanied by changes in stress hormone release
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106955
[Abstract] [OnlineFirst PDF]  

Joris Berwaerts, Adriaan Cleton, Stefaan Rossenu, Krishna Talluri, Bart Remmerie, Luc Janssens, Sandra Boom, Michelle Kramer, and Mariëlle Eerdekens

A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106914
[Abstract] [OnlineFirst PDF]  

July 31, 2009

M Liem-Moolenaar, RWM Zoethout, P de Boer, M Schmidt, ML de Kam, AF Cohen, KL Franson, and JMA van Gerven

The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects
J Psychopharmacol first published on July 31, 2009 as doi:10.1177/0269881109105573
[Abstract] [OnlineFirst PDF]  

SL de Haas, RC Schoemaker, JMA van Gerven, P Hoever, AF Cohen, and J Dingemanse

Pharmacokinetics, pharmacodynamics and the pharmacokinetic/pharmacodynamic relationship of zolpidem in healthy subjects
J Psychopharmacol first published on July 31, 2009 as doi:10.1177/0269881109106898
[Abstract] [OnlineFirst PDF]  

A Weinstein, J Greif, Z Yemini, H Lerman, A Weizman, and E Even-Sapir

Attenuation of cue-induced smoking urges and brain reward activity in smokers treated successfully with bupropion
J Psychopharmacol first published on July 31, 2009 as doi:10.1177/0269881109105456
[Abstract] [OnlineFirst PDF]  

July 22, 2009

JL Mace, RJ Porter, JC Dalrymple-Alford, and TJ Anderson

The effects of acute tryptophan depletion on mood in patients with Parkinson's disease and the healthy elderly
J Psychopharmacol first published on July 22, 2009 as doi:10.1177/0269881109105572
[Abstract] [OnlineFirst PDF]  

July 15, 2009

AJ Schmidt, JC Krieg, HW Clement, S Gebhardt, E Schulz, and P Heiser

Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells
J Psychopharmacol first published on July 15, 2009 as doi:10.1177/0269881109105563
[Abstract] [OnlineFirst PDF]  

June 24, 2009

K Aitchison, K Datla, H Rooprai, J Fernando, and D Dexter

Regional distribution of clomipramine and desmethylclomipramine in rat brain and peripheral organs on chronic clomipramine administration
J Psychopharmacol first published on June 24, 2009 as doi:10.1177/0269881109105789
[Abstract] [OnlineFirst PDF]  

June 19, 2009

Nitin Gupta

Drug–drug interaction primer. A compendium of case vignettes for the practicing clinician
J Psychopharmacol first published on June 19, 2009 as doi:10.1177/0269881109102785
[OnlineFirst PDF]  

June 12, 2009

SE Osunsanmi

Clinical Manual of Child and Adolescent Psychopharmacology
J Psychopharmacol first published on June 12, 2009 as doi:10.1177/0269881108098806
[OnlineFirst PDF]  

KA Wesnes, P Annas, CJ Edgar, C Deeprose, R Karlsten, A Philipp, J Kalliomäki, and M Segerdahl

Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers
J Psychopharmacol first published on June 12, 2009 as doi:10.1177/0269881109105900
[Abstract] [OnlineFirst PDF]  

June 8, 2009

EJH Mulder, L Tegaldo, P Bruschettini, and GHA Visser

Foetal response to maternal coffee intake: role of habitual versus non-habitual caffeine consumption
J Psychopharmacol first published on June 8, 2009 as doi:10.1177/0269881109106310
[Abstract] [OnlineFirst PDF]  

June 3, 2009

SE Winder-Rhodes, SR Chamberlain, MI Idris, TW Robbins, BJ Sahakian, and U Müller

Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers
J Psychopharmacol first published on June 3, 2009 as doi:10.1177/0269881109105899
[Abstract] [OnlineFirst PDF]  

SE Gartside, NC Griffith, V Kaura, and CD Ingram

The neurosteroid dehydroepiandrosterone (DHEA) and its metabolites alter 5-HT neuronal activity via modulation of GABA_A receptors
J Psychopharmacol first published on June 3, 2009 as doi:10.1177/0269881109105836
[Abstract] [OnlineFirst PDF]  

RH Kang, HS Chang, ML Wong, MJ Choi, JY Park, HY Lee, IK Jung, SH Joe, L Kim, SH Kim, YK Kim, CS Han, BJ Ham, HJ Lee, YH Ko, MS Lee, and MS Lee

Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression
J Psychopharmacol first published on June 3, 2009 as doi:10.1177/0269881109105457
[Abstract] [OnlineFirst PDF]  

MJ Taylor, R Norbury, S Murphy, S Rudebeck, P Jezzard, and PJ Cowen

Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers
J Psychopharmacol first published on June 3, 2009 as doi:10.1177/0269881109105679
[Abstract] [Free OnlineFirst PDF]  
SAGE Open article 

June 1, 2009

DE Tenback, PN van Harten, CJ Slooff, and J van Os

Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia
J Psychopharmacol first published on June 1, 2009 as doi:10.1177/0269881109106306
[Abstract] [OnlineFirst PDF]  

DJ Dijk, LM James, S Peters, JK Walsh, and S Deacon

Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep
J Psychopharmacol first published on June 1, 2009 as doi:10.1177/0269881109105788
[Abstract] [OnlineFirst PDF]  

T C Yan, A McQuillin, A Thapar, P Asherson, S P Hunt, S C Stanford, and H Gurling

NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD
J Psychopharmacol first published on June 1, 2009 as doi:10.1177/0269881108100255
[Abstract] [OnlineFirst PDF]  

May 28, 2009

S Vossel, J Kukolja, M Thimm, CM Thiel, and GR Fink

The effect of nicotine on visuospatial attention in chronic spatial neglect depends upon lesion location
J Psychopharmacol first published on May 28, 2009 as doi:10.1177/0269881109105397
[Abstract] [OnlineFirst PDF]  

M X Patel, P M Haddad, I B Chaudhry, S McLoughlin, N Husain, and A S David

Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years
J Psychopharmacol first published on May 28, 2009 as doi:10.1177/0269881109104882
[Abstract] [OnlineFirst PDF]  

N Yasui-Furukori, M Saito, T Nakagami, H Furukori, A Suzuki, T Kondo, and S Kaneko

Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients
J Psychopharmacol first published on May 28, 2009 as doi:10.1177/0269881109104849
[Abstract] [OnlineFirst PDF]  

May 21, 2009

J R Cardoso de Almeida, M L Phillips, C T Cerqueira, M Zilberman, D Lobo, E Henna, H Tavares, E Amaro, C Gorenstein, V Gentil, and G F Busatto

Neural activity changes to emotional stimuli in healthy individuals under chronic use of clomipramine
J Psychopharmacol first published on May 21, 2009 as doi:10.1177/0269881109105786
[Abstract] [OnlineFirst PDF]  

S C Stanford, B J Stanford, and P K Gillman

Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium
J Psychopharmacol first published on May 21, 2009 as doi:10.1177/0269881109105450
[Abstract] [OnlineFirst PDF]  

J L Mace, R J Porter, J C Dalrymple-Alford, K A Wesnes, and T J Anderson

Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson's disease
J Psychopharmacol first published on May 21, 2009 as doi:10.1177/0269881109105721
[Abstract] [OnlineFirst PDF]  

T Schunck, A Mathis, G Erb, I J Namer, A Demazières, and R Luthringer

Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge
J Psychopharmacol first published on May 21, 2009 as doi:10.1177/0269881109104864
[Abstract] [OnlineFirst PDF]  

G Esquivel, K R Schruers, R J Maddock, A Colasanti, and E J Griez

Acids in the brain: a factor in panic?
J Psychopharmacol first published on May 21, 2009 as doi:10.1177/0269881109104847
[Abstract] [OnlineFirst PDF]  

May 7, 2009

P Celec and M Behuliak

Behavioural and endocrine effects of chronic cola intake
J Psychopharmacol first published on May 7, 2009 as doi:10.1177/0269881109105401
[Abstract] [OnlineFirst PDF]  

EL Mullings, LF Donaldson, JK Melichar, and MR Munafò

Effects of acute abstinence and nicotine administration on taste perception in cigarette smokers
J Psychopharmacol first published on May 7, 2009 as doi:10.1177/0269881109105395
[Abstract] [OnlineFirst PDF]  

C Haw and J Stubbs

Off-label psychotropic prescribing for young persons in medium security
J Psychopharmacol first published on May 7, 2009 as doi:10.1177/0269881109105102
[Abstract] [OnlineFirst PDF]  

M Vermeiden, WW van den Broek, PGH Mulder, and TK Birkenhäger

Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients
J Psychopharmacol first published on May 7, 2009 as doi:10.1177/0269881109105137
[Abstract] [OnlineFirst PDF]  

April 30, 2009

LS Volonteri, A Colasanti, G Cerveri, A Fiorentini, IF De Gaspari, MC Mauri, A Valli, P Papa, and C Mencacci

Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels
J Psychopharmacol first published on April 30, 2009 as doi:10.1177/0269881109104863
[Abstract] [OnlineFirst PDF]  

S Fokos and G Panagis

Effects of ⁹-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress
J Psychopharmacol first published on April 30, 2009 as doi:10.1177/0269881109104904
[Abstract] [OnlineFirst PDF]  

HW Chase, A Michael, ET Bullmore, BJ Sahakian, and TW Robbins

Paradoxical enhancement of choice reaction time performance in patients with major depression
J Psychopharmacol first published on April 30, 2009 as doi:10.1177/0269881109104883
[Abstract] [OnlineFirst PDF]  

E Boot, J Booij, JR Zinkstok, L de Haan, DH Linszen, F Baas, and TA van Amelsvoort

Striatal D₂ receptor binding in 22q11 deletion syndrome: an [¹²³I]IBZM SPECT study
J Psychopharmacol first published on April 30, 2009 as doi:10.1177/0269881109104854
[Abstract] [OnlineFirst PDF]  

April 24, 2009

J Harley, R Roberts, P Joyce, R Mulder, S Luty, C Frampton, and M Kennedy

Orosomucoid influences the response to antidepressants in major depressive disorder
J Psychopharmacol first published on April 24, 2009 as doi:10.1177/0269881109105101
[Abstract] [OnlineFirst PDF]  

R Paul, J Minay, C Cardwell, D Fogarty, and C Kelly

Meta-analysis of the effects of lithium usage on serum creatinine levels
J Psychopharmacol first published on April 24, 2009 as doi:10.1177/0269881109104930
[Abstract] [OnlineFirst PDF]  

J-Y Guo, J-Y Wang, and F Luo

Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems
J Psychopharmacol first published on April 24, 2009 as doi:10.1177/0269881109104848
[Abstract] [OnlineFirst PDF]  

J Du, A Zhang, L Wang, J Xuan, L Yu, R Che, X Li, N Gu, Z Lin, G Feng, Q Xing, and L He

Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients
J Psychopharmacol first published on April 24, 2009 as doi:10.1177/0269881109104932
[Abstract] [OnlineFirst PDF]  

V Peritogiannis and S Tsouli

Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature
J Psychopharmacol first published on April 24, 2009 as doi:10.1177/0269881109103827
[Abstract] [OnlineFirst PDF]  

April 7, 2009

PK Thanos, C Bermeo, M Rubinstein, KL Suchland, GJ Wang, DK Grandy, and ND Volkow

Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109102613
[Abstract] [OnlineFirst PDF]  

P Chandra, S Hafizi, RM Massey-Chase, GM Goodwin, PJ Cowen, and CJ Harmer

NK₁ receptor antagonism and emotional processing in healthy volunteers
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109103101
[Abstract] [OnlineFirst PDF]  

A Baldacchino, IB Crome, D Zador, S McGarrol, A Taylor, S Hutchison, T Fahey, M Hickman, and B Kidd

Recording of clinical information in a Scotland-wide drug deaths study
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109103797
[Abstract] [OnlineFirst PDF]  

A Pirona and MJ Morgan

An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109102780
[Abstract] [OnlineFirst PDF]  

I Pampaloni, T Sivakumaran, CJ Hawley, A Al Allaq, J Farrow, S Nelson, and NA Fineberg

High-dose selective serotonin reuptake inhibitors in OCD: a systematic retrospective case notes survey
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109104850
[Abstract] [OnlineFirst PDF]  

M Ghasemi, M Raza, and AR Dehpour

NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109104845
[Abstract] [OnlineFirst PDF]  

E Painsipp, G Sperk, H Herzog, and P Holzer

Delayed stress-induced differences in locomotor and depression-related behaviour in female neuropeptide-Y Y1 receptor knockout mice
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109104851
[Abstract] [OnlineFirst PDF]  

April 3, 2009

T Paparrigopoulos, E Tzavellas, D Karaiskos, P Malitas, and I Liappas

An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109103799
[Abstract] [OnlineFirst PDF]  

CK Thoeringer, A Erhardt, I Sillaber, MB Mueller, F Ohl, F Holsboer, and ME Keck

Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109103091
[Abstract] [OnlineFirst PDF]  

JP Nicolay, S Gatz, F Lang, and UE Lang

Lithium-induced suicidal erythrocyte death
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109102631
[Abstract] [OnlineFirst PDF]  

PC McHugh, GR Rogers, DM Glubb, PR Joyce, and MA Kennedy

Proteomic analysis of rat hippocampus exposed to the antidepressant paroxetine
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109102786
[Abstract] [OnlineFirst PDF]  

S Sütt, S Raud, U Abramov, J Innos, H Luuk, M Plaas, S Kõks, K Zilmer, R Mahlapuu, M Zilmer, and E Vasar

Relation of exploratory behaviour to plasma corticosterone and Wfs1 gene expression in Wistar rats
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109102738
[Abstract] [OnlineFirst PDF]  

G Martinotti, M Di Nicola, D Tedeschi, S Andreoli, D Reina, M Pomponi, M Mazza, R Romanelli, N Moroni, R De Filippis, M Di Giannantonio, G Pozzi, P Bria, and L Janiri

Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109102623
[Abstract] [OnlineFirst PDF]  

SJC Davies, M Esler, and DJ Nutt

Anxiety – bridging the heart/mind divide
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109103800
[Abstract] [OnlineFirst PDF]  

March 27, 2009

F Klumpers, JM van Gerven, EPM Prinssen, I Niklson, F Roesch, WJ Riedel, JL Kenemans, and JMP Baas

Method development studies for repeatedly measuring anxiolytic drug effects in healthy humans
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109103115
[Abstract] [OnlineFirst PDF]  

A Mead and M Li

Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: an interoceptive drug state mechanism
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109102546
[Abstract] [OnlineFirst PDF]  

I Thompson, G Williams, B Caldwell, S Aldington, S Dickson, N Lucas, J McDowall, M Weatherall, G Robinson, and R Beasley

Randomised double-blind, placebo-controlled trial of the effects of the ‘party pills' BZP/TFMPP alone and in combination with alcohol
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109102608
[Abstract] [OnlineFirst PDF]  

MJ Hunt, M Falinska, and S Kasicki

Local injection of MK801 modifies oscillatory activity in the nucleus accumbens in awake rats
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109102539
[Abstract] [OnlineFirst PDF]  

RM Abou El-Magd, HK Park, T Kawazoe, S Iwana, K Ono, SP Chung, M Miyano, K Yorita, T Sakai, and K Fukui

The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of Schizophrenia
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109102644
[Abstract] [OnlineFirst PDF]  

GD Cooper, AJ Goudie, and JCG Halford

Acute effects of olanzapine on behavioural expression including the behavioural satiety sequence in female rats
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109102543
[Abstract] [OnlineFirst PDF]  

VSL Williams, HM Edin, SL Hogue, SE Fehnel, and DS Baldwin

Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109102779
[Abstract] [OnlineFirst PDF]  

March 20, 2009

J Daumann, D Wagner, K Heekeren, A Neukirch, CM Thiel, and E Gouzoulis-Mayfrank

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109103227
[Abstract] [OnlineFirst PDF]  

JC Shan, MH Hsieh, CC Liu, CC Wen, and CM Liu

Clinical alertness to valproic acid-induced hyperammonemia—two case reports
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109102635
[OnlineFirst PDF]  

FM Van der Veen, EAT Evers, GW Mies, EFPM Vuurman, and J Jolles

Acute tryptophan depletion selectively attenuates cardiac slowing in an Eriksen flanker task
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109103801
[Abstract] [OnlineFirst PDF]  

E Sacchetti, C Turrina, B Cesana, and G Mazzaglia

Timing of stroke in elderly people exposed to typical and atypical antipsychotics: a replication cohort study after the paper of Kleijer, et al.
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109103202
[OnlineFirst PDF]  

M Wienberg, BY Glenthoj, KS Jensen, and B Oranje

A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109102606
[Abstract] [OnlineFirst PDF]  

MX Patel, N de Zoysa, M Bernadt, J Bindman, and AS David

Are depot antipsychotics more coercive than tablets?
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109103133
[Abstract] [OnlineFirst PDF]  

MG Bossong, TM Brunt, JP Van Dijk, SM Rigter, J Hoek, HMJ Goldschmidt, and RJM Niesink

mCPP: an undesired addition to the ecstasy market
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109102541
[Abstract] [OnlineFirst PDF]  

JL Wilkinson, FI Carroll, and RA Bevins

An investigation of bupropion substitution for the interoceptive stimulus effects of nicotine
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109102518
[Abstract] [OnlineFirst PDF]  

V Raj, HC Liang, ND Woodward, AL Bauernfeind, J Lee, MS Dietrich, S Park, and RL Cowan

MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109103203
[Abstract] [OnlineFirst PDF]  

RK Singh, C Jia, F Garcia, GA Carrasco, G Battaglia, and NA Muma

Activation of the JAK-STAT pathway by olanzapine is necessary for desensitization of serotonin2A receptor–stimulated phospholipase C signaling in rat frontal cortex but not serotonin2A receptor–stimulated hormone release
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109103090
[Abstract] [OnlineFirst PDF]  

RIG Holt, T Abdelrahman, M Hirsch, Z Dhesi, T George, T Blincoe, and RC Peveler

The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109102788
[Abstract] [OnlineFirst PDF]  

March 13, 2009

MR Munafò, JE Bailey, A Diaper, RM Cooper, CP Benton, IS Penton-Voak, and DJ Nutt

RETRACTION: Effects of 7.5% CO₂ inhalation on allocation of spatial attention to facial cues of emotional expression
J Psychopharmacol first published on March 13, 2009 as doi:10.1177/0269881108096981
[OnlineFirst PDF]  

March 12, 2009

R Molteni, F Calabrese, S Chourbaji, C Brandwein, G Racagni, P Gass*, and MA Riva*

Depression-prone mice with reduced glucocorticoid receptor expression display an altered stress-dependent regulation of brain-derived neurotrophic factor and activity-regulated cytoskeleton-associated protein
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881108099815
[Abstract] [OnlineFirst PDF]  

ML Lu, CH Chen, HC Liu, PY Chen, SH Yu, and CC Chiu

RETRACTION: The biphasic changes of insulin secretion in schizophrenic patients treated with olanzapine
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881108094888
[OnlineFirst PDF]  

P Heiser, O Sommer, AJ Schmidt, HW Clement, A Hoinkes, UT Hopt, E Schulz, JC Krieg, and E Dobschütz

Effects of antipsychotics and vitamin C on the formation of reactive oxygen species
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881109102538
[Abstract] [OnlineFirst PDF]  

J Seguí, F López-Muñoz, C Álamo, X Camarasa, P García-García, and A Pardo

Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective study
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881109102641
[Abstract] [OnlineFirst PDF]  

T Uzbay, H Kayir, G Goktalay, and M Yildirim

Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881109102533
[Abstract] [OnlineFirst PDF]  

E Bianchi, D Lehmann, E Vivoli, M Norcini, and C Ghelardini

Involvement of PLC-₃ in the effect of morphine on memory retrieval in passive avoidance task
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881108102013
[Abstract] [OnlineFirst PDF]  

BC Jones, S Ben-Hamida, A Pereira de Vasconcelos, C Kelche, C Lazarus, R Jackisch, and JC Cassel

Effects of ethanol and ecstasy on conditioned place preference in the rat
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881109102775
[Abstract] [OnlineFirst PDF]  

J Harley, S Luty, J Carter, R Mulder, and P Joyce

Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881109102770
[OnlineFirst PDF]  

D Taylor and V Cornelius

Risperidone long-acting injection: factors associated with changes in bed stay and hospitalisation in a 3-year naturalistic follow-up
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881109102611
[Abstract] [OnlineFirst PDF]  

March 5, 2009

S Ratcliffe, M Younus, M Hauben, and L Reich

Antidepressants that inhibit neuronal norepinephrine reuptake are not associated with increased spontaneous reporting of cardiomyopathy
J Psychopharmacol first published on March 5, 2009 as doi:10.1177/0269881108100776
[Abstract] [OnlineFirst PDF]  

SL McLean, ML Woolley, and JC Neill

Effects of subchronic phencyclidine on behaviour of female rats on the elevated plus maze and open field
J Psychopharmacol first published on March 5, 2009 as doi:10.1177/0269881109103112
[Abstract] [OnlineFirst PDF]  

A Attard, G Ranjith, and D Taylor

Alternative routes to oral antidepressant therapy: case vignette and literature review
J Psychopharmacol first published on March 5, 2009 as doi:10.1177/0269881109102545
[OnlineFirst PDF]  

RP Markus, DG Franco, LA Carvalho, V Gentil, and C Gorenstein

Acute increase in urinary 6-sulfatoximelatonin after clomipramine, as a predictive measure for emotional improvement
J Psychopharmacol first published on March 5, 2009 as doi:10.1177/0269881109102542
[Abstract] [OnlineFirst PDF]  

R Hanwella, V de Silva, C Wijeratne, T Ketharanathan, and J de Silva

Clozapine-associated weight loss
J Psychopharmacol first published on March 5, 2009 as doi:10.1177/0269881109102530
[Abstract] [OnlineFirst PDF]  

M Kuloglu, O Ekinci, and A Caykoylu

Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone
J Psychopharmacol first published on March 5, 2009 as doi:10.1177/0269881109102612
[OnlineFirst PDF]  

February 27, 2009

KA Brennan, RA Lea, PS Fitzmaurice, and P Truman

Nicotinic receptors and stages of nicotine dependence
J Psychopharmacol first published on February 27, 2009 as doi:10.1177/0269881108100256
[Abstract] [OnlineFirst PDF]  

C Garcia-Leal, CM Del-Ben, FM Leal, FG Graeff, and FS Guimarães

Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation
J Psychopharmacol first published on February 27, 2009 as doi:10.1177/0269881108101782
[Abstract] [OnlineFirst PDF]  

February 24, 2009

C Bushe, J Sniadecki, AJ Bradley, and V Poole Hoffmann

Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia
J Psychopharmacol first published on February 24, 2009 as doi:10.1177/0269881108101783
[Abstract] [OnlineFirst PDF]  

AA-B Badawy

Plasma free tryptophan revisited: what you need to know and do before measuring it
J Psychopharmacol first published on February 24, 2009 as doi:10.1177/0269881108098965
[Abstract] [OnlineFirst PDF]  

B Boland, L Mitcheson, and K Wolff

Lhermitte's sign, Electric shock sensations and high dose ecstasy consumption: preliminary findings
J Psychopharmacol first published on February 24, 2009 as doi:10.1177/0269881108100528
[Abstract] [OnlineFirst PDF]  

February 9, 2009

SJ Mathew, RB Price, DC Shungu, X Mao, ELP Smith, JM Amiel, and JD Coplan

A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder
J Psychopharmacol first published on February 9, 2009 as doi:10.1177/0269881108101796
[Abstract] [OnlineFirst PDF]  

J Cilia, JE Gartlon, C Shilliam, LA Dawson, SH Moore, and DNC Jones

Further neurochemical and behavioural investigation of Brattleboro rats as a putative model of schizophrenia
J Psychopharmacol first published on February 9, 2009 as doi:10.1177/0269881108098787
[Abstract] [OnlineFirst PDF]  

January 22, 2009

K Hewett, W Chrzanowski, R Jokinen, R Felgentreff, RK Shrivastava, MD Gee, DS Wightman, MC O'Leary, LS Millen, MC Leon, MA Briggs, A Krishen, and JG Modell

Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100254
[Abstract] [OnlineFirst PDF]  

M Rezayat, H Niasari, S Ahmadi, L Parsaei, and MR Zarrindast

N-methyl-D-aspartate receptors are involved in lithium-induced state-dependent learning in mice
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100093
[Abstract] [OnlineFirst PDF]  

JB Diniz, RG Shavitt, CAB Pereira, AG Hounie, I Pimentel, LM Koran, SM Dainesi, and EC Miguel

Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108099423
[Abstract] [OnlineFirst PDF]  

D Élie, M Poirier, JM Chianetta, M Durand, CA Grégoire, and S Grignon

Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100777
[Abstract] [OnlineFirst PDF]  

AC Mishra and B Mohanty

Effect of lactational exposure of olanzapine on body weight of mice: a comparative study on neonates of both the sexes during post-natal development
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100775
[Abstract] [OnlineFirst PDF]  

P Shajahan and M Taylor

The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100774
[Abstract] [OnlineFirst PDF]  

J Nielsen, M Dahm, H Lublin, and D Taylor

Psychiatrists' attitude towards and knowledge of clozapine treatment
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100320
[Abstract] [OnlineFirst PDF]  

OJ Robinson, R Cools, MJ Crockett, and BJ Sahakian

Mood state moderates the role of serotonin in cognitive biases
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100257
[Abstract] [OnlineFirst PDF]  

GJH Dumont, RC Schoemaker, DJ Touw, FCGJ Sweep, JK Buitelaar, JMA van Gerven, and RJ Verkes

Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108099214
[Abstract] [OnlineFirst PDF]  

SR Hodgson, RS Hofford, SG Buckman, PJ Wellman, and S Eitan

Morphine-induced stereotyped thigmotaxis could appear as enhanced fear and anxiety in some behavioural tests
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100797
[Abstract] [OnlineFirst PDF]  

K Boora, K Chiappone, S Dubovsky, and J Xu

Ziprasidone-induced spontaneous orgasm
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100321
[Abstract] [OnlineFirst PDF]  

December 12, 2008

JA Milstein, JW Dalley, and TW Robbins

Methylphenidate-induced impulsivity: pharmacological antagonism by -adrenoreceptor blockade
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108098146
[Abstract] [OnlineFirst PDF]  

GJH Dumont, C Kramers, FCGJ Sweep, JJ Willemsen, DJ Touw, RC Schoemaker, JMA van Gerven, JK Buitelaar, and RJ Verkes

Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108100020
[Abstract] [OnlineFirst PDF]  

K Sugden, CM Pariante, P McGuffin, KJ Aitchison, and UM D'Souza

Housekeeping gene expression is affected by antidepressant treatment in a mouse fibroblast cell line
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108099690
[Abstract] [OnlineFirst PDF]  

M Kuloglu, A Caykoylu, O Ekinci, D Bayindirli, G Vural, and O Deniz

Successful management of depression with reboxetine in a patient who developed parkinsonism related to paroxetine use
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108099962
[OnlineFirst PDF]  

LAW Jans, GAH Korte-Bouws, SM Korte, and A Blokland

The effects of acute tryptophan depletion on affective behaviour and cognition in Brown Norway and Sprague Dawley rats
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108099424
[Abstract] [OnlineFirst PDF]  

E Vieta, T Ramey, D Keller, PA English, AD Loebel, and J Miceli

Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108099418
[Abstract] [OnlineFirst PDF]  

M Poyurovsky, I Glick, and LM Koran

Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108099215
[Abstract] [OnlineFirst PDF]  

MA van Duinen, KRJ Schruers, and EJL Griez

Desynchrony of fear in phobic exposure
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108098821
[Abstract] [OnlineFirst PDF]  

CA Hendrie

The funding crisis in psychopharmacology: an historical perspective
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108100253
[OnlineFirst PDF]  

November 27, 2008

HY Chan, CJ Chang, SC Chiang, JJ Chen, CH Chen, HJ Sun, HG Hwu, and MS Lai

A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism
J Psychopharmacol first published on November 27, 2008 as doi:10.1177/0269881108096070
[Abstract] [OnlineFirst PDF]  

November 21, 2008

JL Kenemans, W Hebly, EHM van den Heuvel, and T Grent-'T-Jong

Moderate alcohol disrupts a mechanism for detection of rare events in human visual cortex
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108098868
[Abstract] [OnlineFirst PDF]  

A Caykoylu, O Ekinci, M Kuloglu, and O Deniz

Aripiprazole-induced rabbit syndrome: a case report
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108098145
[Abstract] [OnlineFirst PDF]  

LN Ravindran, SM Jung, and AV Ravindran

Intravenous anti-obsessive agents: a review
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096508
[Abstract] [OnlineFirst PDF]  

AL Montejo, N Prieto, A Terleira, J Matias, S Alonso, G Paniagua, S Naval, DG Parra, C Gabriel, E Mocaër, and A Portolés

Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096507
[Abstract] [OnlineFirst PDF]  

JCG Halford, EJ Boyland, SJ Cooper*, TM Dovey, MSB Huda, CT Dourish, GR Dawson, and JPH Wilding

The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095195
[Abstract] [OnlineFirst PDF]  

AW Zuardi, JAS Crippa, SM Dursun, SL Morais, JAA Vilela, RF Sanches, and JEC Hallak

Cannabidiol was ineffective for manic episode of bipolar affective disorder
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096521
[Abstract] [OnlineFirst PDF]  

SL McLean, B Grayson, M Harris, C Protheroe, S Bate, ML Woolley, and JC Neill

Isolation rearing impairs novel object recognition and attentional set shifting performance in female rats
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108093842
[Abstract] [OnlineFirst PDF]  

S Bae, JE Kim, J Hwang, YS Lee, HH Lee, J Lee, IK Lyoo, PF Renshaw, and SJ Yoon

Increased prevalence of white matter hyperintensities in patients with panic disorder
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108098476
[Abstract] [OnlineFirst PDF]  

L Zuurman, C Roy, RC Schoemaker, A Amatsaleh, L Guimaeres, JL Pinquier, AF Cohen, and JMA van Gerven

Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096509
[Abstract] [OnlineFirst PDF]  

KJ Wagner, M Valet, EF Kochs, M Kriner, TR Tölle, and T Sprenger

The µ-opioid receptor agonist remifentanil induces acute dysphoria irrespective of its analgesic properties
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095811
[Abstract] [OnlineFirst PDF]  

N Cheesman and D Taylor

Psychosis and depression associated with alteration to amiodarone therapy
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095717
[Abstract] [OnlineFirst PDF]  

L Craig, JE Fisk, C Montgomery, PN Murphy, and M Wareing

Is emotional intelligence impaired in ecstasy-polydrug users?
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095713
[Abstract] [OnlineFirst PDF]  

FI Tarazi, T Moran-Gates, EHF Wong, B Henry, and M Shahid

Asenapine induces differential regional effects on serotonin receptor subtypes
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095704
[Abstract] [OnlineFirst PDF]  

RZ Goldstein, PA Woicik, SJ Moeller, F Telang, M Jayne, C Wong, GJ Wang, JS Fowler, and ND Volkow

Liking and wanting of drug and non-drug rewards in active cocaine users: the STRAP-R questionnaire
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096982
[Abstract] [OnlineFirst PDF]  

AJ Schmidt, JC Krieg, HW Clement, UM Hemmeter, E Schulz, H Vedder, and P Heiser

Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096506
[Abstract] [OnlineFirst PDF]  

A.F. Buchmann, M. Laucht, B. Schmid, K. Wiedemann, K. Mann, and U.S. Zimmermann

Cigarette craving increases after a psychosocial stress test and is related to cortisol stress response but not to dependence scores in daily smokers
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095716
[Abstract] [OnlineFirst PDF]  

N Ahuja, N Palanichamy, P Mackin, and AJ Lloyd

Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096901
[Abstract] [OnlineFirst PDF]  

R Ghanbari, M El Mansari, and P Blier

Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095714
[Abstract] [OnlineFirst PDF]  

S Bellino, E Paradiso, P Bozzatello, and F Bogetto

Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095715
[Abstract] [OnlineFirst PDF]  

GE Jacobs, IMC Kamerling, ML de Kam, RH DeRijk, J van Pelt, FG Zitman, and JMA van Gerven

Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108094299
[Abstract] [OnlineFirst PDF]  

WTCJ Heijnen, WW van den Broek, PGH Mulder, and TK Birkenhäger

Prevalence of trait anxiety in a sample of depressed inpatients and its influence on response to antidepressants
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108099213
[Abstract] [OnlineFirst PDF]  

D Van Dam, K Coen, and PP De Deyn

Ibuprofen modifies cognitive disease progression in an Alzheimer's mouse model
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108097630
[Abstract] [OnlineFirst PDF]  

KP Hayhurst, RJ Drake, and SW Lewis

Patient factors associated with receipt of combination antipsychotic drug therapy in the treatment of schizophrenia
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095169
[Abstract] [OnlineFirst PDF]  

M Liem-Moolenaar, FA Gray, SJ de Visser, KL Franson, RC Schoemaker, JAJ Schmitt, AF Cohen, and JMA van Gerven

Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108094524
[Abstract] [OnlineFirst PDF]  

S Pallanti, S Bernardi, A Allen, W Chaplin, D Watner, CM DeCaria, and E Hollander

Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108099419
[Abstract] [OnlineFirst PDF]  

D Dickerson, B Pittman, E Ralevski, A Perrino, D Limoncelli, J Edgecombe, G Acampora, JH Krystal, and I Petrakis

Ethanol-like effects of thiopental and ketamine in healthy humans
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108098612
[Abstract] [OnlineFirst PDF]  

November 14, 2008

G Laretzaki, S Plainis, S Argyropoulos, IG Pallikaris, and P Bitsios

Threat and anxiety affect visual contrast perception
J Psychopharmacol first published on November 14, 2008 as doi:10.1177/0269881108098823
[Abstract] [OnlineFirst PDF]  

S Bernardi and S Pallanti

Successful duloxetine treatment of a binge eating disorder: a case report
J Psychopharmacol first published on November 14, 2008 as doi:10.1177/0269881108098822
[Abstract] [OnlineFirst PDF]  

Ö Uzun

Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report
J Psychopharmacol first published on November 14, 2008 as doi:10.1177/0269881108098809
[Abstract] [OnlineFirst PDF]  

October 28, 2008

AKK Chung and SE Chua

Torsade de pointes associated with low-dose amisulpride: a case report
J Psychopharmacol first published on October 28, 2008 as doi:10.1177/0269881108098385
[OnlineFirst PDF]  

October 6, 2008

AA Gibbs, KH Naudts, EP Spencer, and AS David

Effects of amisulpride on emotional memory using a dual-process model in healthy male volunteers
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097722
[Abstract] [OnlineFirst PDF]  

C Norman, SK Grimond-Billa, GW Bennett, and HJ Cassaday

A neurotensin agonist and antagonist decrease and increase activity, respectively, but do not preclude discrete cue conditioning
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097721
[Abstract] [OnlineFirst PDF]  

S Flaisher-Grinberg, N Kronfeld-Schor, and H Einat

Models of mania: from facets to domains and from animal models to model animals
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097905
[OnlineFirst PDF]  

K Domschke, J Deckert, V Arolt, and BT Baune

Anxious versus non-anxious depression: difference in treatment outcome
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097723
[OnlineFirst PDF]  

EA Del-Bel, FS Guimarães, SRL Joca, MB Echeverry, and FR Ferreira

Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097717
[Abstract] [OnlineFirst PDF]  

V De Luca, S Tharmalingam, C Zai, N Potapova, J Strauss, J Vincent, and JL Kennedy

Association of HPA axis genes with suicidal behaviour in schizophrenia
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097817
[Abstract] [OnlineFirst PDF]  

Luísa W. Bisol and Diogo R. Lara

Low-dose quetiapine for patients with dysregulation of hyperthymic and cyclothymic temperaments
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097715
[Abstract] [OnlineFirst PDF]  

SD Hood, JP Potokar, SJC Davies, DA Hince, K Morris, KM Seddon, DJ Nutt, and SV Argyropoulos

Dopaminergic challenges in social anxiety disorder: evidence for dopamine D₃ desensitisation following successful treatment with serotonergic antidepressants
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108098144
[Abstract] [OnlineFirst PDF]  

October 2, 2008

DW Boulton, AH Balch, K Royzman, CG Patel, RM Berman, S Mallikaarjun, and RA Reeves

The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108096522
[Abstract] [OnlineFirst PDF]  

R Whale, T Terao, P Cowen, N Freemantle, and J Geddes

Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108097714
[Abstract] [OnlineFirst PDF]  

C Chiamulera, V Tedesco, L Zangrandi, C Giuliano, and G Fumagalli

Propranolol transiently inhibits reinstatement of nicotine-seeking behaviour in rats
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108097718
[Abstract] [OnlineFirst PDF]  

G Bedi, NT Van Dam, and J Redman

Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108097631
[Abstract] [OnlineFirst PDF]  

JR Davidson, W Zhang, KM Connor, J Ji, K Jobson, Y Lecrubier, AC McFarlane, DJ Newport, DJ Nutt, DN Osser, DJ Stein, ZN Stowe, O Tajima, and M Versiani

A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108096505
[Abstract] [OnlineFirst PDF]  

I Labuschagne, RJ Croft, KL Phan, and PJ Nathan

Augmenting serotonin neurotransmission with citalopram modulates emotional expression decoding but not structural encoding of moderate intensity sad facial emotional stimuli: an event-related potential (ERP) investigation
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108097878
[Abstract] [OnlineFirst PDF]  

SJ Kish, PS Fitzmaurice, LJ Chang, Y Furukawa, and J Tong

Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108097724
[Abstract] [OnlineFirst PDF]  

A Papadopoulos, A Rich, DJ Nutt, and JE Bailey

The effects of single dose anxiolytic medication on the CO₂ models of anxiety: differentiation of subjective and objective measures
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108097716
[Abstract] [OnlineFirst PDF]  

September 18, 2008

L E Hill, S K Droste, D J Nutt, A C E Linthorst, and J M H M Reul

Voluntary exercise alters GABA_A receptor subunit and glutamic acid decarboxylase-67 gene expression in the rat forebrain
J Psychopharmacol first published on September 18, 2008 as doi:10.1177/0269881108096983
[Abstract] [OnlineFirst PDF]  

A Whitworth, C Stuppaeck, K Yazdi, K Kralovec, C Geretsegger, G Zernig, and W Aichhorn

Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months
J Psychopharmacol first published on September 18, 2008 as doi:10.1177/0269881108096504
[Abstract] [OnlineFirst PDF]  

May 30, 2008

A Tint, P M Haddad, and I M Anderson

The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study
J Psychopharmacol first published on May 30, 2008 as doi:10.1177/0269881107087488
[Abstract] [OnlineFirst PDF]